Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Effects of beta-glucans on the immune system.

Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E.

Medicina (Kaunas). 2007;43(8):597-606. Review.

2.

Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

Hong F, Hansen RD, Yan J, Allendorf DJ, Baran JT, Ostroff GR, Ross GD.

Cancer Res. 2003 Dec 15;63(24):9023-31.

3.

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.

Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD.

J Immunol. 2004 Jul 15;173(2):797-806.

4.

The effects of beta-glucan on human immune and cancer cells.

Chan GC, Chan WK, Sze DM.

J Hematol Oncol. 2009 Jun 10;2:25. doi: 10.1186/1756-8722-2-25. Review.

5.

Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley.

Akramiene D, Grazeliene G, Didziapetriene J, Kevelaitis E.

Medicina (Kaunas). 2009;45(6):480-5.

7.

Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.

Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE, Yan J.

J Immunol. 2006 Aug 1;177(3):1661-9.

8.
10.

Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans.

Chen J, Seviour R.

Mycol Res. 2007 Jun;111(Pt 6):635-52. Epub 2007 Mar 7. Review.

PMID:
17590323
11.

Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.

Xiang D, Sharma VR, Freter CE, Yan J.

Curr Med Chem. 2012;19(25):4298-305. Review.

PMID:
22834812
12.

Effects of mushroom-derived beta-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-kappaB transactivation in Caco-2 reporter cells: can effects be explained by structure?

Volman JJ, Helsper JP, Wei S, Baars JJ, van Griensven LJ, Sonnenberg AS, Mensink RP, Plat J.

Mol Nutr Food Res. 2010 Feb;54(2):268-76. doi: 10.1002/mnfr.200900009.

PMID:
19885842
13.

Therapeutic intervention with complement and beta-glucan in cancer.

Ross GD, Vetvicka V, Yan J, Xia Y, Vetvicková J.

Immunopharmacology. 1999 May;42(1-3):61-74. Review.

PMID:
10408367
14.

Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides.

Wasser SP.

Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74. Epub 2002 Sep 10. Review.

PMID:
12436306
15.
16.

The effects of β-glucans on dendritic cells and implications for cancer therapy.

Albeituni SH, Yan J.

Anticancer Agents Med Chem. 2013 Jun;13(5):689-98. Review.

PMID:
23092290
17.

[Mobilization of mesenchymal infection defense].

Seljelid R, Raa J.

Tidsskr Nor Laegeforen. 2002 Dec 10;122(30):2891-4. Review. Norwegian.

PMID:
12569716
18.

Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).

Thornton BP, Vĕtvicka V, Pitman M, Goldman RC, Ross GD.

J Immunol. 1996 Feb 1;156(3):1235-46.

PMID:
8558003
19.

[Biologically active compounds of edible mushrooms and their beneficial impact on health].

Rajewska J, Bałasińska B.

Postepy Hig Med Dosw (Online). 2004;58:352-7. Review. Polish.

20.

Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.

Yoon TJ, Kim TJ, Lee H, Shin KS, Yun YP, Moon WK, Kim DW, Lee KH.

Int Immunopharmacol. 2008 Jan;8(1):36-42. Epub 2007 Oct 30.

PMID:
18068098
Items per page

Supplemental Content

Write to the Help Desk